Suppr超能文献

[皮肤恶性黑色素瘤干扰素治疗中的双侧视网膜微血管病变]

[Bilateral retinal microangiopathy in interferon therapy of malignant melanoma of the skin].

作者信息

Neubauer A S, Hoops J P

机构信息

Augenklinik der Ludwig-Maximilians-Universität, Mathildenstr. 8, 80336 München.

出版信息

Klin Monbl Augenheilkd. 2000 Nov;217(5):308-11. doi: 10.1055/s-2000-10374.

Abstract

BACKGROUND

Interferon associated retinopathy has been described mainly by Japanese working groups as a complication of systemic interferon therapy for various diseases. In Europe, only few reports exist, especially regarding interferon therapy for dermal malignant melanoma.

PATIENT

We report a 58-year-old female patient with symptomatic, bilateral microangiopathy caused by interferon for metastatic dermal malignant melanoma. Multiple bilateral cotton wool spots caused visual field defects and unilateral decreased visual acuity. The retinal changes were reversible when stopping interferon therapy.

CONCLUSION

Interferon-associated microangiopathy occurs as a complication of interferon therapy independently of the treated systemic disease. Rarely, retinopathy becomes symptomatic as reported in this case. Symptoms were fully, clinical signs were partially reversible. A regular ophthalmologic monitoring of all patients receiving interferon therapy is recommended. Monitoring aims to detecting vision-threatening retinal changes in a reversible phase.

摘要

背景

干扰素相关性视网膜病变主要由日本研究团队描述为各种疾病全身应用干扰素治疗的一种并发症。在欧洲,相关报道较少,尤其是关于皮肤恶性黑色素瘤的干扰素治疗。

患者

我们报告一名58岁女性患者,因转移性皮肤恶性黑色素瘤接受干扰素治疗而出现有症状的双侧微血管病变。双侧多个棉絮斑导致视野缺损和单眼视力下降。停用干扰素治疗后视网膜病变可逆转。

结论

干扰素相关性微血管病变作为干扰素治疗的并发症出现,与所治疗的全身性疾病无关。如本病例报道,视网膜病变很少出现症状。症状完全缓解,临床体征部分可逆。建议对所有接受干扰素治疗的患者进行定期眼科监测。监测旨在发现处于可逆阶段的威胁视力的视网膜病变。

相似文献

3
[Ocular complications of adjuvant interferon therapy for malignant melanoma: a review].
Hautarzt. 2003 Feb;54(2):144-7. doi: 10.1007/s00105-002-0409-x. Epub 2003 Jan 15.

引用本文的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验